New hope for easing the agony of opioid withdrawal
NCT ID NCT05995535
Summary
This study is testing whether adding pregabalin to lofexidine helps people with opioid addiction better manage withdrawal symptoms when trying to stop using opioids. The trial involves 150 adults who want to start a long-acting medication called naltrexone for their addiction. Participants will receive either the two-drug combination or lofexidine with a placebo, then be offered the naltrexone treatment if they complete withdrawal.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mountain Manor Treatment Center
NOT_YET_RECRUITINGBaltimore, Maryland, 21229-3618, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Pennsylvania, Treatment Research Center
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.